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Because immune responses simultaneously defend
and injure the host, the immune system must be
finely regulated to ensure the host’s survival. Here,
we have shown that when injected with high Toll-
like receptor ligand doses or infected with lympho-
cytic choriomeningitis virus (LCMV) clone 13, which
has a high viral turnover, inflammatory monocyte-
derived dendritic cells (Mo-DCs) engulfed apoptotic
erythroid cells. In this process, called hemophagocy-
tosis, phosphatidylserine (PS) served as an ‘‘eat-me’’
signal. Type I interferons were necessary for both PS
exposure on erythroid cells and the expression of PS
receptors in the Mo-DCs. Importantly, hemophago-
cytosis was required for interleukin-10 (IL-10) pro-
duction from Mo-DCs. Blocking hemophagocytosis
or Mo-DC-derived IL-10 significantly increased cyto-
toxic T cell lymphocyte activity, tissue damage, and
mortality in virus-infected hosts, suggesting that
hemophagocytosis moderates immune responses
to ensure the host’s survival in vivo. This sheds light
on the physiological relevance of hemophagocytosis
in severe inflammatory and infectious diseases.
INTRODUCTION
An immune response is a two-edged sword that, while directly
attacking a pathogen, simultaneously damages the body
(Schneider and Ayres, 2008). In an infected host, dendritic cells
(DCs) and other innate immune cells sense pathogens through
receptors that detect pathogen-associated molecular patterns
(PAMPs) or damage-associated molecular patterns (DAMPs).
These danger signals trigger DCmaturation and induce immuno-584 Immunity 39, 584–598, September 19, 2013 ª2013 Elsevier Inc.genic DCs that produce inflammatory cytokines and activate
both the innate and adaptive immune systems. The adaptive
immune system eliminates the pathogen in an antigen (Ag)-
specific manner and protects the host from reinfection (Medzhi-
tov and Janeway, 1997; Banchereau et al., 2000; Cooper and
Alder, 2006). However, infection-induced immune responses,
particularly virus-specific cytotoxic T lymphocytes (CTLs), cyto-
kines, and chemical mediators, simultaneously damage tissue
(Clark, 2007; Lambeth, 2007; Rouse and Sehrawat, 2010).
Therefore, immune responses require regulatory machinery to
maintain the fine balance between defense and self-injury during
infections; the more severe the infection, the greater the regula-
tory control must be. However, little attention has been paid to
the nature of the machinery balancing these immune-response
effects. This study focuses on hemophagocytosis, which is
conventionally viewed as an indicator of severe inflammation,
and identifies DC-mediated hemophagocytosis as the machin-
ery that fine-tunes immune responses and ensures host survival
under severe inflammatory and infectious conditions.RESULTS
Toll-like Receptor Ligands Induce Hemophagocytosis
Pattern recognition receptors (PRRs), including Toll-like recep-
tors (TLRs) and nucleotide oligomerization domain (NOD)-like
receptors (NLRs), sensemicrobial infection andmediate immune
and inflammatory responses (Kawai and Akira, 2010). In this
study, we found that high doses (200 mg) of various TLR and
NLR ligands injected into wild-type (WT) mice induced hemo-
phagocytosis, an indicator of severe inflammatory conditions
such as hemophagocytic syndrome (Larroche and Mouthon,
2004; Janka, 2007; Maakaroun et al., 2010). Hemophagocytosis,
typically defined as the engulfment of TER119+ erythroid cells by
CD11c+ cells, was detected by the presence of CD11c+TER119+
cells in the peripheral blood. Of the ligands used, unmethylated
CpG DNA (CpG) and poly I:C induced hemophagocytosis in
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CpG, the number of CD11c+TER119+ cells in the peripheral
blood increased according to the CpG dosage, peaking 18 hr
later in the bone marrow (BM) and peripheral blood and 3 days
afterward in the spleen (see Figures S1A–S1D available online).
This suggested that hemophagocytosis in the peripheral blood
correlated well with and reflected that in the BM. Sorted CD11c+
TER119+ cells displayed typical hemophagocytosis with both
attached and internalized erythroid cells by Diff-Quick stain
and electron microscopic analysis (Figures 1B and 1C). CpG
also induced other criteria of hemophagocytic syndrome,
including fever, splenomegaly, cytopenia (evaluated by the
reduction of hemoglobin and platelets), and hypertriglyceridemia
(Figures S1E–S1I). We used a recently reported protocol (Zoller
et al., 2011) to further confirm the intracellular localization of
erythroid cells inside CD11c+ cells. In brief, TER119 exposed
on CD11c+ cell surfaces was blocked with saturating amounts
of an unlabeled antibody (Ab) against TER119 and then stained
with an anti-TER119 Ab. As expected, intracellular TER119
was stained after permeabilization in a CpG dose-dependent
manner (Figure S1J). These results clearly demonstrated the
intracellular localization of erythroid cells and correlated well
with those of CD11c+TER119+ staining without permeabilization
(Figure S1D). This is reasonable because hemophagocytosis is a
sequential event: apoptotic erythroid cells expressing phospha-
tidylserine (PS) are initially attached to PS receptors on the
CD11c+ cells and then are gradually phagocytosed into the cells.
Hemophagocytosing DCs Are of Monocyte Origin
The phenotype of the hemophagocytosing CD11c+ cells was
major histocompatibility complex (MHC) class IIloCD11bhiF4/
80+Gr-1hiCD40CD80hiCD86 (Figure 1D). This is characteristic
of inflammatory monocyte-derived DCs (Mo-DCs), which are
induced under inflammatory conditions (Randolph et al., 1999;
Leo´n et al., 2007; Serbina et al., 2008; Auffray et al., 2009; Geiss-
mann et al., 2010). To confirm the Mo-DCs’ origin, we sorted
inflammatory monocytes, defined as Ly6chiCX3CR1
intCD11b+
CD11c cells, from the BM of Cx3cr1
GFP/+ mice (CD45.1
CD45.2+), which expressed EGFP under the endogenous
Cx3cr1 locus (Jung et al., 2000) (Figure S2A). We injected these
cells into WT mice (CD45.1+CD45.2) and then injected CpG.
After 18 hr, the transferred inflammatorymonocytes had become
CD11c+, and approximately 40% were engulfing TER119+ cells
(Figures 1E and 1F). In Cx3cr1
GFP/+ mice injected directly with
CpG, the hemophagocytes consisted mostly of Ly6chiCX3CR1
int
inflammatory monocyte-derived DCs (Figure S2B), indicating
that inflammatory monocytes were the major hemophagocyte
precursor. During infection and inflammation, inflammatory
monocytes mobilize from the BM to the periphery CCR2 depen-
dently (Boring et al., 1997; Serbina and Pamer, 2006). Because
CpG-induced hemophagocytosis is mediated by Mo-DCs, we
conducted experiments with Ccr2/ mice, in which circulating
monocytes are able to leave the BM but inflammatory mono-
cytes cannot. In WT mice, serum amounts of the CCR2 ligands
CCL2, CCL7, and CCL12 peaked 3–6 hr after CpG injection (Fig-
ures 2A–2C); CCR2 was predominantly expressed on Ly6chi
inflammatory monocytes and to a lesser extent on CD11c+
TER119+ cells (Figure 2D). Importantly, the percentage of periph-
eral blood CD11c+TER119+ cells after CpG injection was greatlyImreduced in the Ccr2/ mice (Boring et al., 1997), partially
reduced in Ccl2/ mice (Lu et al., 1998)—probably due to
CCL7 and CCL12, which are also CCR2 ligands—and unaf-
fected in Cx3cr1
GFP/GFP mice (Figure 2E). In contrast, the BM
CD11c+TER119+ cell numbers after CpG injection were compa-
rable between theWT andCcr2/mice (Figure 2F). Collectively,
these results demonstrate that CpG injection causes inflamma-
tory monocytes to mobilize to the periphery, differentiate into
Mo-DCs, and engulf mainly erythroid cells.
Involvement of ‘‘Find Me’’ and ‘‘Eat Me’’ Signals in TLR
Ligand-Induced Hemophagocytosis
Cells undergoing apoptosis release ‘‘find me’’ signals to recruit
phagocytes and expose PS, which is recognized by phagocytes
as an ‘‘eat me’’ signal, on their surface (Nagata et al., 2010; Mar-
tin et al., 1996). PS is recognized directly by T cell immunoglob-
ulin- and mucin-domain-containing (Tim)-1 and -4 and indirectly
by the aVb3 and aVb5 integrins throughmilk-fat globule epidermal
growth factor (EGF) factor 8 (MFG-E8), and by Tyro3, Axl, and
Mer (TAM) family members through Gas6 and protein S (Martin
et al., 1996; Hanayama et al., 2002; Kobayashi et al., 2007; Miya-
nishi et al., 2007; Nakayama et al., 2009). We next examined the
roles of ‘‘find me’’ and ‘‘eat me’’ signals in CpG-induced hemo-
phagocytosis. Serum amounts of ATP, recently identified as a
‘‘find me’’ signal (Elliott et al., 2009), increased rapidly after
CpG injection, peaking 6 hr later (Figure 3A). The ATP receptor
P2Y2 was predominantly expressed on Ly6chi inflammatory
monocytes, on BMDCs, and on Mo-DCs performing hemopha-
gocytosis (CD11c+TER119+), but not on T or B cells (Figure 3B),
suggesting that ATP is an important ‘‘find me’’ signal in hemo-
phagocytosis. Indeed, injecting suramin, a competitive inhibitor
of ATP-P2Y2 binding, effectively blocked the CpG-induced
hemophagocytosis (Figure 3C).
Next, we examined the role of the ‘‘eat me’’ signal in CpG-
induced hemophagocytosis. The number of apoptotic erythroid
cells expressingPS, definedasannexinV+TER119+cells, peaked
2–4 hr after CpG injection (Figure 3D). In this context, most of the
apoptotic cells were TER119+ erythroid cells, and some
apoptotic Gr-1hiLy6c+ granulocytes were also detected (Figures
S3A–S3C).CpG-inducedMo-DCswere themajor phagocytes for
TER119+ erythroid cells (data not shown). As ‘‘eat me’’ signal re-
ceptors, theMo-DCs expressed Tim1, Tim4, and aV and b3 integ-
rin (Figure 3E), and an injection of neutralizing Abs against ‘‘eat
me’’ signal receptors significantly blocked hemophagocytosis
(Figure 3F). CpG injection induced the production of the repre-
sentative regulatory cytokine interleukin-10 (IL-10) in the periph-
eral blood at rates that increased with CpG dosage (Figure 3G),
and this correlated well with hemophagocytosis (Figure S1D).
Consistent with these results, excessiveCpGstimulation triggers
DC IL-10 production (Waibler et al., 2008). Of note, injecting PS
receptor-neutralizing Abs, which prevents hemophagocytosis,
significantly reduced the IL-10 production (Figure 3G). Injecting
a high dose of poly I:C into WT mice produced similar results,
with Mo-DCs (Figure S3D) and ‘‘find me’’ and ‘‘eat me’’ signals
playing critical roles in the poly I:C-induced hemophagocytosis
and accompanying IL-10 production (Figures S3E–S3G). Collec-
tively, these results suggest that ‘‘find me’’ and ‘‘eat me’’ signals
are critical for CpG-induced hemophagocytosis and that high
CpG doses induce IL-10 production.munity 39, 584–598, September 19, 2013 ª2013 Elsevier Inc. 585
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Figure 1. TLR Ligands Induce Hemophagocytosis
(A) Hemophagocytosis (%) in the peripheral blood of WT mice 18 hr after an injection of PBS (vehicle) or the indicated TLR or NLR ligand.
(B) Sorted CD11c+TER119+ cells from the BM of CpG-injected mice were stained with Diff-Quick. Red and black arrows indicate hemophagocytosed and
attached erythroid cells, respectively. Original magnification was 3100.
(C) Sorted CD11c+TER119+ cells from the peripheral blood of CpG injected mice were analyzed by electron microscope. Scale bar represents 1 mm. Arrows
indicate hemophagocytosed erythroid cells.
(legend continued on next page)
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Figure 2. CCR2 Is Involved in Developing CpG-Induced Hemophagocytosis
(A–C) Kinetics of serum CCL2 (A), CCL7 (B), and CCL12 (C) production in WT mice after 200-mg CpG injection.
(D) Relative Ccr2 mRNA expression in the indicated cell populations from WT mice 18 hr after 200-mg CpG injection. BMDC, bone marrow-derived DCs.
(E and F) Percentage of CD11c+TER119+ cells in the peripheral blood (E) and BM (F) of the indicated mice 18 hr after 200 mg CpG injection. Data represent the
mean ± SD of three independent experiments. *p < 0.01, **p < 0.05. See also Figure S2.
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Hemophagocytosis
On the basis of these findings, we examined the induction mech-
anism and physiological relevance of hemophagocytosis in virus(D) Cell-surface staining of CD11c+TER119+ cells in the peripheral blood of 200
(E and F) Analysis of the peripheral blood progeny of BM inflammatory monocytes
(CX3CR1
GFP/intLy6chiCD11b+CD11c, CD45.2+, 1 3 106) were transplanted into
periments. *p < 0.01 and **p < 0.05. See also Figure S1.
Iminfection. We used the lymphocytic choriomeningitis virus
(LCMV) variant clone 13 (C13), which elicits a chronic infection
(Matloubian et al., 1990), for two reasons. First, compared with
the original LCMV Armstrong (Arm), C13 binds and infects DCsmg CpG-injected WT mice after blocking with an unlabeled anti-TER119 Ab.
18 hr after vehicle (E) or 200 mg CpG (F) injection. BM inflammatory monocytes
WT mice (CD45.1+). Data represent the mean ± SD of three independent ex-
munity 39, 584–598, September 19, 2013 ª2013 Elsevier Inc. 587
A B
C D
E
F G
Figure 3. ‘‘Find Me’’ and ‘‘Eat Me’’ Signals in CpG-Induced Hemophagocytosis
(A) Serum ATP amount over time in WT mice after 200 mg CpG injection.
(B) Relative P2y2 mRNA expression in CD11c+TER119+ cells from the peripheral blood and the indicated BM-derived cell populations 18 hr after 200 mg CpG
injection.
(C) Percentage of CD11c+TER119+ cells in the peripheral blood of WT mice 18 hr after 200 mg CpG injection with 6 mg suramin.
(D) Percentage of annexin V+ cells among TER119+ cells in the peripheral blood of WT mice over time after PBS (vehicle) or 200 mg CpG injection.
(E) Expression of ‘‘eat me’’ signal receptors on CpG-induced CD11c+TER119+ cells. Shaded histograms represent cells stained with mAbs for the indicated
molecules, and open histograms show labeling with isotype controls.
(legend continued on next page)
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Hemophagocytosis to Fine-Tune Immune Responseswith high affinity, and it proliferates vigorously owing to two
amino acid changes in its glycoprotein and polymerase, resulting
in remarkably high viral nucleic acid amounts in vivo (Sevilla
et al., 2000), possibly mimicking the effect of high-dose CpG
or poly I:C injection. In this context, we expected that the more
severe the infection, the more closely regulated the response.
Second, most viruses that induce hemophagocytosis produce
a chronic infection in humans (Clark 2007; Lambeth, 2007;
Rouse and Sehrawat, 2010), although the role of hemophagocy-
tosis in chronic infection is unknown. Indeed, the mRNA
amounts for viral glycoprotein (GP) and nucleoprotein (NP) in
C13-infected cells were remarkably higher than in Arm-infected
cells, and we found that inflammatory monocytes, which are
Mo-DC precursors, were a major C13 infection target (Fig-
ure S4A). As expected from these results, hemophagocytosis
was induced more efficiently in C13-infected WT mice than in
Arm-infected WT mice (Figure S4B); the intracellular localization
of erythroid cells was again confirmed with the Diff-Quick stain-
ing and recently reported protocol (Zoller et al., 2011) (Fig-
ure S4C; data not shown). As with CpG injection, most of the
apoptotic cells were TER119+ erythroid cells and some were
apoptotic Gr-1hiLy6c+ granulocytes, suggesting that the contri-
bution of apoptotic granulocytes was not negligible but relatively
low (Figures S4D–S4F). In contrast, lymphocyte populations,
including T, B, and NK cells, rarely became apoptotic at the
same time point after C13 infection.
C13 infection induced type I interferon (IFN) production (Fig-
ures 4A and 4B). Interestingly, C13 infection-induced hemopha-
gocytosis was significantly reduced in mice deficient for
interferon-a receptor 1 (IFNAR1), a component of the type I
IFN-receptor (Figures 4C and 4D). Consistent with these results,
C13 infection in Ifnar1/ mice severely impaired the PS expo-
sure on erythroid cells and the Tim-1, Tim-4, and aV and b3 integ-
rin expression on Mo-DCs (Figures 4E–4G), suggesting that type
I IFNs are essential both for inducing PS on erythroid cells and for
the development of Mo-DCs that express PS receptors. Indeed,
ex vivo IFN-a stimulation directly induced the apoptosis of
TER119+ erythroid cells and, to a lesser extent, Gr-1hiLy6c+
granulocytes (Figure S4G). In addition, IFN-a stimulation directly
induced expression of PS receptors, i.e., Tim-1, Tim-4, and aV
and b3 integrin, on inflammatory monocytes, precursors of
Mo-DCs (Figures S4H and S4I). These results suggested that
type I IFNs were necessary for both PS exposure on erythroid
cells and the expression of PS receptors on the Mo-DCs.
Hemophagocytes Are the Major Source of IL-10
Finally, we examined the physiological relevance of hemophago-
cytosis in C13 infection. As expected from our findings thus far,
injecting neutralizing Abs against Tim-1, Tim-4, and aVb3 into
C13-infected WT mice significantly suppressed hemophago-
cytosis (Figure 5A). Milk-fat globule epidermal growth factor 8
(MFG-E8) contains a PS-binding domain and an arginine-
glycine-aspartate (RGD) motif, which binds to both avb3 and
avb5 integrin on phagocytic cells, and it mediates the integrin-(F) Impaired CpG-induced hemophagocytosis in the peripheral blood of WT mic
CD11c+TER119+ cells 18 hr after 200 mg CpG injection with isotype control Ab co
mixture of antibodies against Tim1, Tim4, avb3.
(G) IL-10 serum amounts 24 hr after the indicated treatments. Data represent the
Imdependent engulfment of apoptotic cells and subsequent
signaling (Hanayama et al., 2002; Akakura et al., 2003). As
expected, Mfge8 was clearly expressed in both inflammatory
monocytes, a precursor of Mo-DCs, and Mo-DCs performing
hemophagocytosis, whereas expression of other PS receptors
including Bai1, Stab2, Tyro3, Axl, Mertk, Gas6 detected by
qPCR (Figure S5A) and Stabilin-2, Tyro-3, Axl, MerTK by specific
Ab staining (Figure S5B) was minimal, suggesting that these
molecules are unlikely involved in the uptake of apoptotic
erythroid cells by Mo-DCs. Serum amounts of IL-10 and trans-
forming growth factor b1 (TGF-b1), both of which suppress
immune responses, increased after C13 infection, peaking at
24 hr (Figure 5B; data not shown). In line with our findings, C13
infection induces IL-10, contributing to the virus persistence
in vivo (Brooks et al., 2006), although themechanismof IL-10 pro-
duction remains unknown. Importantly, injecting Abs against the
Mo-DC PS receptors, which block hemophagocytosis, effec-
tively reduced the IL-10 and TGF-b1 production (Figure 5B),
whereas injecting IL-10-neutralizing Abs into WT mice did not
suppress hemophagocytosis (Figure 5A). This suggests that the
IL-10 production fromMo-DCs in response toC13 infection is he-
mophagocytosis-dependent. In this context, blocking IL-10 ac-
tivity substantially reduced the TGF-b1 serum amounts, implying
that IL-10 somehow regulates TGF-b1 production in C13-in-
fected WT mice (Figure 5B). In the peripheral blood of C13-in-
fected Il10Venus reportermice (Atarashi et al., 2011), IL-10was ex-
pressedpredominantly inCD11c+TER119+ cells andnot in T cells
(Figure 5C), and the absolute number of IL-10Venus+ CD11c+-
TER119+ cells was much greater than that of IL-10Venus+ cells
belonging to other populations, including CD11c+TER119 cells
(Figure 5D). This clearly demonstrates that hemophagocytes are
the major source of IL-10 at an early phase of infection in vivo.
To further examine the IL-10 production machinery from
Mo-DCs in response to C13 infection, we established ex vivo
hemophagocytosis assay system, in which TER119 Mo-DCs
and TER119+ erythroid cells, separately sorted from the BM of
C13-infected WT mice, were cocultured (Figure 6A). Of note,
the erythroid cells were pHrodo-labeled prior to the coculture,
which allowed the erythroid cells transported into lysosomes
upon hemophagocytosis to be detected by their increased light
emission under the acidic conditions. Consistent with the in vivo
results, hemophagocytosis was clearly induced ex vivo (Fig-
ure 6A, left panel, 6B, and 6C). Most importantly, ex vivo
blockage of hemophagocytosis with Abs against the Mo-DC’s
PS receptor impaired Mo-DC-derived IL-10 production (Fig-
ure 6A, right panel, 6D, and 6E). In this context, adding blocking
Abs against Tim-1 and Tim-4 did not affect IL-10 production,
whereas blocking Abs against integrin avb3 or avb5 significantly
reduced the amount of IL-10 production (Figure 6E). In addition,
neither blocking internalization of apoptotic erythroid cells with
cytochalasin D nor opsonization of them induced Mo-DC-
derived IL-10 production (Figure 6E). These results collectively
demonstrated that IL-10 production from Mo-DCs is largely
dependent on the integrin-mediated signals. Similar resultse treated with blocking antibodies against Tim1, Tim4, avb3. The proportion of
cktails (500 mg each) or the indicated antibody mixtures (500 mg each). Ab mix,
mean ± SD of three independent experiments. *p < 0.01. See also Figure S3.
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Figure 4. Essential Role of Type I IFNs in C13-Induced Hemophagocytosis
(A and B) Kinetics of serum IFN-a (A) and IFN-b (B) production in WT mice after 2 3 106 pfu C13 infection.
(C) Representative flow cytometry (FCM) profiles of CD11c+TER119+ cells in the peripheral blood of WT and Ifnar1/mice 24 hr after 23 106 pfu C13 infection.
(D and E) The percentage of CD11c+TER119+ cells (D) and annexin V+ cells among TER119+ cells (E) in the peripheral blood of WT mice 4 hr and 24 hr after
injection of 2 3 106 pfu C13, respectively.
(F and G) Expression of ‘‘eat me’’ signal receptors on CD11c+TER119+ cells in the peripheral blood of WT (F) and Ifnar1/ (G) mice 24 hr after 2 3 106 pfu C13
infection. Shaded histograms represent cells stained with mAbs specific for the indicated molecules, and open histograms show labeling with isotype controls.
Data represent the mean ± SD of three independent experiments. *p < 0.01. See also Figure S4.
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cytes, the other apoptotic population in C13-infected mice
(Figures S4D and S4E), were used in the same experiment (Fig-
ure S6A). Notably, the amounts of IL-10 secreted from the
Mo-DCs that engulfed erythroid cells were 60 pg/ml and, from
those that engulfed granulocytes, were 40 pg/ml in the same590 Immunity 39, 584–598, September 19, 2013 ª2013 Elsevier Inc.experiment (Figure 6E; Figure S6A). These results suggested
that granulocytes are slightly less potent on a per-cell basis
than erythroid cells for inducing IL-10 secretion from Mo-DCs.
To definitively show the contribution of these integrins to the
IL-10 secretion from Mo-DCs, we performed ex vivo hemopha-
gocytosis assay, in which Mo-DCs and erythroid cells, sorted
AC
B
D
Figure 5. Hemophagocytosis-Dependent IL-10 Production from MO-DCs upon C13 Infection
(A) C13-induced hemophagocytosis in the peripheral blood ofWTmice treated with either isotype control Ab cocktails (500 mg each), blocking antibodies against
PS receptors, or IL-10 (500 mg each).
(B) IL-10 and TGF-b1 serum amounts 24 hr after C13 infection with the injection of isotype control Ab cocktails (500 mg each), Abs to block PS receptors or
neutralize IL-10.
(C) A representative FCM profile of IL-10 Venus expression in the indicated cell populations from the peripheral blood of Il10Venus reporter mice 24 hr after C13
infection.
(D) The absolute number of cells expressing IL-10 Venus in the indicated cell populations from the peripheral blood of Il10Venus reporter andWTmice 1 and 9 days
after C13 infection. Data represent the mean ± SD from three independent experiments. *p < 0.01. See also Figure S5.
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infection, were cocultured in all combinations (Figure 6F). Impor-
tantly, the IL-10 secretion was selectively impaired when
Mfge8/Mo-DCs were used for the coculture, demonstrating
that the IL-10 secretion from Mo-DCs is MFG-E8-mediated
and thus dependent on both integrin avb3 and avb5 (Figure 6F).
We also examined the apoptotic status of these cells during
later time points; i.e., 8, 16, and 24 days after the infection. The
numbers of apoptotic erythroid cells were much reduced and
comparable to those of granulocytes (Figure S6B), and the
numbers of IL-10 producing cells were substantially lower,
compared with that at an early phase of infection (Figure S6C).
As observed at an early phase of infection, lymphocyte popula-
tions, i.e., T and B cells, hardly became apoptotic during later
time points (Figure S6B). These results implied that erythroid
cells and granulocytes equally contribute to phagocytosis-medi-
ated IL-10 production during later phase of infection.
Hemophagocytosis Prevents Immune-Responses-
Mediated Damage and Ensure the Host’s Survival
What is the physiological relevance of the hemophagocyte-
derived IL-10 in viral infection? Interestingly, blockingImhemophagocytosis with PS receptor Abs or IL-10 activity with
IL-10-neutralizing Ab enhanced the virus-specific CTL induction
(Figures 7A and 7B), CTL-mediated liver-damage (Zinkernagel
et al., 1986) (serum AST and ALT) (Figure 7C), and mortality (Fig-
ure 7D). In the context of CTL activity, we also found that block-
ing hemophagocytosis or IL-10 activity diminished the CTL
expression of PD-1 (data not shown), which causes CTL
exhaustion in C13 infection (Barber et al., 2006). Because
Tim-1- and Tim-4-signaling can alter immune responses in
some cases (Xiao et al., 2007, 2011; Rodriguez-Manzanet
et al., 2008), we examined whether anti-Tim-1 and anti-Tim-4
Abs could modulate immune responses in C13-infected WT
mice. However, injecting anti-Tim-1 and anti-Tim-4 Abs did
not alter the frequency of hemophagocytosis in the peripheral
blood, IL-10 amounts and C13 virus titers in the sera, and per-
centage and absolute number of IL-10Venus+ CD11c+TER119+
cells (data not shown), suggesting that these Abs do not signif-
icantly affect virus-specific immune responses in vivo, at least in
this experimental setting.
To further confirm the importance of the hemophagocyte-
derived IL-10 in fine-tuning excessive immune responses
in vivo, we infected Cd11c-cre Il10fl/fl mice, in which themunity 39, 584–598, September 19, 2013 ª2013 Elsevier Inc. 591
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Figure 6. Critical Role of MFG-E8-Integrin Signal in IL-10 Production from Mo-DCs
(A–F) Ex vivo hemophagocytosis assay. TER119 Mo-DCs and TER119+ erythroid cells were separately sorted from the BM of LCMV C13 infected WT or
Mfge8/ mice. The Mo-DCs were pretreated with control rat Ig (A, left panel, and C) or Abs to block PS receptors (B, right panel, and D), and cocultured with
pHrodo-labeled TER119+ erythroid cells for 2 hr. The cells were stained with Diff-Quick. Red arrows indicate hemophagocytes. Original magnification, x20 (A).
Representative FCM profiles of Mo-DCs cocultured with unlabeled- (B), pHrodo-labeled-erythroid cells (C and D). IL-10 amount in the indicated coculture su-
pernatants is shown (E and F). Data represent the mean ± SD of three independent experiments. *p < 0.01. See also Figure S6.
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numbers of Mo-DCs performing hemophagocytosis in C13-in-
fected Cd11c-cre Il10fl/fl mice were comparable to those seen592 Immunity 39, 584–598, September 19, 2013 ª2013 Elsevier Inc.in control WT mice (Figure 7E), the serum IL-10 production was
greatly reduced (Figure 7F), confirming that hemophagocytes
were the major source of IL-10 in vivo under these infectious
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Hemophagocytosis to Fine-Tune Immune Responsesconditions. As with WT mice in which hemophagocytosis was
blocked, the Cd11c-cre Il10fl/fl mice showed excessive CTL
activity, tissue damage, and mortality when infected with C13
(Figure 7G–7J). Taken together, these results point to hemopha-
gocytosis as machinery for preventing excessive immune
response-mediated damage, thus assuring the host’s survival
in the face of severe viral infection.
In summary, our findings indicate that hemophago-
cytosis induced by C13 infection occurs in sequential steps
(Figure S7).
DISCUSSION
We found that hemophagocytosis could be detected by stain-
ing with and without permeabilization. In this context, we
would like to stress that hemophagocytosis is a sequential
event; that is, apoptotic erythroid cells exposing PS are initially
attached to PS receptors expressed on the Mo-DCs and are
then gradually phagocytosed into the cells. Therefore, even
without permeabilization, these cells can be detected as
CD11c+TER119+ cells. Supporting the specific recognition of
apoptotic erythroid cells by PS receptors on Mo-DCs, hemo-
phagocytosis detected without permeabilization was signifi-
cantly reduced in WT mice in which hemophagocytosis was
blocked with anti-PS receptor Abs or with suramin, a compet-
itive inhibitor of ATP-P2Y2 binding. In C13-infected Ifnar1/
mice, both PS exposure on erythroid cells and PS receptor
induction on Mo-DCs were impaired, suggesting that type I
IFNs are critically involved in these processes. Because it is
well known that CpG injection induces type I IFN production,
it is likely that CpG-induced type I IFNs induce apoptosis of
erythroid cells. Indeed, ex vivo IFN-a stimulation directly
induced apoptosis of erythroid cells. F4/80+ macrophages
are reported to be the hemophagocytosis-performing cells in
the spleen of mice infused with IFN-g (Zoller et al., 2011). In
this context, we found that the hemophagocytosis-performing
Mo-DCs clearly expressed F4/80, suggesting that the previ-
ously reported F4/80+ macrophages and the Mo-DCs are
presumably overlapping populations (Domı´nguez and Ardavı´n,
2010).
The uptake of experimentally (UV-irradiation, staurosporine,
etc.) induced apoptotic peripheral blood lymphocytes,
neutrophils, and peripheral blood T cells or Jurkat T cells by
phagocytes induces IL-10 production, which suppresses proin-
flammatory cytokine production (Voll et al., 1997; Byrne and
Reen, 2002; Kim et al., 2004). However, it remains unknown
whether such ex vivo observations are consistent with and
represent the in vivo situation under severe inflammatory con-
ditions. Remarkably, we showed that, upon CpG injection or
LCMV C13 infection, most of the apoptotic cells were erythroid
cells and a small number were granulocytes. As a result,
Mo-DCs preferentially engulfed apoptotic erythroid cells, lead-
ing to IL-10 production. Given these findings, we do not
exclude the contribution of granulocytes, although it is relatively
minor, to the IL-10 secretion from Mo-DCs. Consistent with our
findings, the type I IFN-dependent apoptosis of erythroid cells,
but not of neutrophils or monocytes, is observed in DNase II-
deficient mice (Kawane et al., 2001; Yoshida et al., 2005).
These results suggested that type I IFN signaling is requiredImfor the recruitment of nucleated erythroid cells to the peripheral
blood and that, compared with other hematopoietic cells,
erythroid cells are relatively sensitive to type I IFN signaling
and therefore become apoptotic. Indeed, IFN-a induces
apoptosis in human erythroid cells (Tarumi et al., 1995).
Notably, these phenotypes observed in DNase II-deficient
mice are consistent with those in WT mice injected with CpG
or infected with C13.
Although hemophagocytosis is viewed as an indicator of
hemophagocytic syndrome and other severe inflammatory con-
ditions (Clark 2007; Lambeth, 2007; Rouse and Sehrawat, 2010),
our findings suggest that it rather represents a possible
biomarker of anti-inflammatory responses in the host. Very
recently, it was reported that repeatedly injecting CpG induces
hemophagocytic syndrome-like or macrophage activation syn-
drome-like disease in mice (Behrens et al., 2011). When IL-10
signaling is blocked in this model, a more severe disease with
larger numbers of hemophagocytosis develops, raising two pos-
sibilities; first, hemophagocytosis contributes to the severity of
the disease, and second, it is induced, as a negative feedback
machinery, to suppress severe inflammatory responses.We pro-
pose here that hemophagocytosis is a prerequisite for IL-10 pro-
duction and that IL-10 is secreted by Mo-DCs in a manner
dependent on hemophagocytosis, leading to anti-inflammatory
effects of IL-10 to fine-tune immune responses. In humans,
hemoglobin uptake by CD163+ macrophages induces the
expression of the anti-inflammatory heme oxygenase (HO-1)
ex vivo (Schaer et al., 2006a), and HO-1 expression is detected
in hemophagocytic CD163+ macrophages in the BM of patients
with fatal sepsis (Schaer et al., 2006b). Interestingly, CD163
expression is inducible by IL-10, implying that this anti-inflam-
matory pathway might also contribute to the prevention of
immune responses in vivo.
In acute infections, pathogen growth correlates well with indi-
cators of deteriorating health, and inducing immune responses
usually restores health by reducing the pathogen load. However,
our findings show that, during severe viral infections, immune
responses unaccompanied by efficient hemophagocytosis-
mediated fine-tuning lead to a further deterioration in health
and eventually to severe immune response-mediated self-dam-
age, despite the virus being effectively eradicated. Of interest,
aberrant immune activation with impaired IFN-a expression, a
possible cause of limited hemophagocytosis, was evident in
macaques infected with the 1918 Spanish pandemic virus (Ko-
basa et al., 2007).
The more severe the infection, the stronger the immune
response must be. The stronger the immune response, the
greater the regulatory control must be. Given that most viruses
that cause hemophagocytosis, including Epstein-Barr virus,
cytomegalovirus, and HIV (Larroche and Mouthon, 2004; Janka,
2007; Maakaroun et al., 2010), establish chronic infections in
humans (Clerici et al., 1996; Nordøy et al., 2000; Budiani et al.,
2002), the induction of hemophagocytosis might allow the virus
to persist in the host, ensuring host survival by preventing im-
mune response-mediated damage. Considering this trade-off
between host and pathogen, our findings may be valuable not
only in extending our understanding of immune biology but also
in identifying therapeutic targets for severe inflammatory
diseases.munity 39, 584–598, September 19, 2013 ª2013 Elsevier Inc. 593
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Mice
C57BL/6J (B6, Clea), B6.Cx3cr1
GFP/+ (Jackson) (Jung et al., 2000), B6.Ccr2/
(Jackson) (Boring et al., 1997), B6.Ccl2/ (Lu et al., 1998), B6.Ifnar1/ (B&K
Universal), B6.Il-10Venus (Atarashi et al., 2011), B6.Cd11c-Cre (Jackson)
(Stranges et al., 2007), B6.Mfge8/ (Hanayama et al., 2004), and B6.Il10fl/fl
(Roers et al., 2004) mice were maintained in our SPF facility. All animal exper-
iments were approved by the Institutional Animal Care Committees of Akita
University and Tokyo Medical and Dental University.
Reagents and In Vivo Injection
LPS, MDP, and cytochalasin D were purchased from Sigma-Aldrich. Other re-
agents were obtained as follows: poly I:C (GE Healthcare), R848 (Invivogen),
CpG (ODN-1668 [50-TCCATGACGTTCCTGATGCT-30]; Hokkaido System
Science), iE-DAP (Invivogen), and recombinant mouse interferon-a (Dainion
Sumitomo Pharma). Mice were intravenously (i.v.) injected with TLR ligands
(200 mg poly I:C, 100 mg LPS, 100 mg R848, or 200 mg CpG) or Nod ligands
(100 mg iE-DAP or 100 mg MDP). Mice were infected by i.v. injection of viruses
(2 3 106 pfu LCMV Armstrong or Clone 13).
Diff-Quick Stain
CD11c+TER119+ cells were sorted from the BM of CpG-injected or LCMV
C13-infected mice, cytospun at 500 g for 5 min onto a slide glass, and stained
with Diff-Quick (Sysmex).
Electron Microscopy
CD11c+TER119+ cells were sorted from the peripheral blood of CpG-injected
mice, fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer pH7.2,
washed overnight at 4cC in the same buffer, and postfixed with 1% OsO4
at 4C for 2 hr. Then, the cells were dehydrated in a graded in a series of
ethanol and embedded in Epon 812. Ultrathin (1 mm) sections were collected
on copper grids and with uranyl acetate and lead citrate and then examined
by transmission electron microscope, H-7100 (Hitachi).
Hemophagocytosis Blocking
To block ATP activity, we intraperitoneally (i.p.) injected 6 mg suramin into
WT mice 30 min after CpG or poly I:C injection or 3 and 6 days after C13
infection. To block ‘‘eat me’’ signal receptors, we gave WT mice 500 mg
rat IgG (control) or 500 mg anti-Tim-1 mAb (RMT1-10) (Nakayama et al.,
2009), 500 mg anti-Tim-4 mAb (RMT4-54) (Nakayama et al., 2009), 500 mg
anti-aV mAb (RMV-7) (Takahashi et al., 1990), or 500 mg anti-b3 mAb
(HMb3-1) (Yasuda et al., 1995), or isotype control Ab cocktails including
rat IgG2a, rat IgG2c, and hamster IgG (500 mg of each) by i.v., singly or in
combination as indicated, 60 min and 120 min after CpG injection or viral
infection. To block cytokines, we injected 500 mg rat IgG (control) or
500 mg anti-IL-10 (JES5-2A5) i.p. into WT mice 1 day and 3 days after C13
infection.
ELISAs
Cytokine and chemokine serum amounts were determined by ELISA kits
according to the manufacturer’s instructions (CCL2, IL-10, and TGF-b1,
R&D; CCL7 and CCL12, Bender Med Systems). ATP, AST, and ALT serum
amounts were determined by a luciferin-luciferase assay with an ATP assay
kit (Toyo Ink) and a Fuji DRI-CHEM 3500 V analyzer (Fuji Medical Systems),
respectively, according to the manufacturer’s instructions.Figure 7. Physiological Significance of C13 Infection-Induced Hemoph
(A–C) Percentage of LCMV GP33–41-specific CD8
+ T cells in the spleen (A), tite
uninfected WT mice and WT mice 9 days after LCMV C13 infection, with or with
(D) Survival (%) of WT mice after LCMV C13 infection with or without the injectio
(E–J) Hemophagocytosis (%) (E) and IL-10 amounts (F) in the peripheral blood of
CD8+ T cells in the spleen (G), titer of LCMV C13 in the serum (H), and amount of A
infection and survival (%) of WT or Cd11c-cre Il10fl/fl mice after LCMV C13 infect
0.01. See also Figure S7.
ImFlow Cytometric Analysis and Cell Sorting
Antibodies against the followingmolecules were used for flow cytometric anal-
ysis and cell sorting: CD3ε (145-2C11), CD11b (M1/70), CD11c (N418),
TER119 (TER119), CD19 (MB19-1), CD40 (1C10), CD80 (16-10A1), CD86
(GL19), NK1.1 (PK136), MHC class II (I-A and I-E; M 5/114.15.2), aV (RMV-7),
b3 (2C9.G3), PD-1 (RMP1-30) (all from eBioscience), F4/80 (BM8) (Biolegend),
and Ly6c (AL-219) (BD), Stabilin-2 (#34-2) (MBL), Tryo-3 (109646), Axl
(175128), and MerTK (108921) (all from R&D). Antibodies against Tim-1
(RMT1-17), Tim-3 (RMT3-23), and Tim-4 (RMT4-53) were as described previ-
ously (Nakayama et al., 2009). To analyze hemophagocytosis, we used two
protocols. First, peripheral blood samples were collected into heparin-
containing tubes and immediately maintained on ice. Red blood cells were
lysed by adding 10 ml ACK buffer to the samples and keeping them on ice
for 10 min. After washing with cold PBS, the samples were stained with
APC-anti-CD11c, PE-anti-CD11b, and FITC-anti-TER119. This protocol de-
tected apoptotic erythroid cells exposed on Mo-DC surfaces, including
cells attached to Mo-DC PS receptors or undergoing phagocytosis. Second,
a recently reported protocol was used to detect the intracellular localization
of apoptotic erythroid cells (Zoller et al., 2011). In detail, TER119 exposed on
MO-DC surfaces was first blocked with saturating amounts of an unlabeled
Ab against TER119 (10 mg/10 ml) and then permeabilized with a BD
Cytofix/Cytoperm kit (BD) and stained with FITC-anti-TER119 and APC-anti-
CD11c Abs. Apoptotic cells were detected with PE-annexin V (BD) according
to the manufacturer’s instructions. To purify inflammatory monocytes,
defined as CX3CR1+Ly6chiCD11b+CD11c cells, we pre-enriched BM CD3
ε
CD19NK1.1 cells from Cx3cr1
GFP/+ mice by using a PE-Cy5-conjugated
antibody mixture (CD3 ε, CD19, NK1.1), Cy5 microbeads, and an
AutoMACSpro separation system (Miltenyi Biotec). The cells were then
stained with biotin-anti-Ly6c, PE-anti-CD11b, and APC-anti-CD11c anti-
bodies, secondarily labeled with streptavidin-PE-Cy7, sorted on a MoFlo
instrument (Beckman Coulter), and analyzed on a FACSCanto II (BD) in
conjunction with FlowJo software (TreeStar).
CTL Response and Virus Titer Detection
Splenocytes were harvested 9 days after infection. To detect LCMV-specific
CTL, splenocytes were stained with FITC-anti-CD8 (KT15) (MBL), APC-anti-
CD3ε, and PE-H-2Db-LCMV gp33–41 tetramer (MBL). IFN-g induction was
analyzed by stimulating splenocytes with an LCMV H-2Db-binding peptide
(gp33–41, KAVYNFATM; Peptide Institute), 50 U/ml murine IL-2, and Golgi
Stop (BD) prior to incubation with CD8a antibodies. Cells were then fixed
and stained with IFN-g-PE antibodies in PermWash solution (BD) according
to the manufacturer’s recommendation. For virus titration, MC57G cells
were incubated with 10-fold serial dilutions of LCMV-containing serum in a
24-well plate at 37C for 48 hr. Cells were then fixed with 4% formalin, permea-
bilized with 0.5% Triton X, and incubated with 10% fetal bovine serum. After
incubation with murine LCMV immunoglobulin G1 (IgG1; Progen Biotechnik)
and anti-mouse IgG-horseradish peroxidase (GE Healthcare), the plates
were stained with an AEC peroxidase substrate kit (Vector Laboratories) and
virus plaques were counted for each well.
Quantitative RT-PCR
Total RNA was extracted with an RNeasy Mini Kit (QIAGEN), and cDNA was
synthesized with random hexamers and SuperScript III reverse transcriptase.
For real-time PCR, cDNA products equivalent to RNA from 2,000 cells were
amplified with a LightCycler480 and SYBR Green I Master (Roche Diagnos-
tics). The data were normalized to the amounts of gapdh RNA expression in
each sample. The primers used for real-time PCR were as follows: Ccr2, 50-ATagocytosis
r of LCMV C13 in the serum (B), and amount of AST/ALT in the serum (C) of
out the injection of Abs to block PS receptors or neutralize IL-10.
n of Abs to block PS receptors.
WT mice 24 hr after C13 infection. The percentage of LCMV GP33–41-specific
ST and ALT in the serum (I) of WT and Cd11c-cre Il10fl/fl mice 9 days after C13
ion (J). Data represent the mean ± SD of three independent experiments. *p <
munity 39, 584–598, September 19, 2013 ª2013 Elsevier Inc. 595
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Hemophagocytosis to Fine-Tune Immune ResponsesGAGTAACTGTGTGATTGACAAGCA-30 (sense) and 50-GCAGCAGTGTGT
CATTCCAAGA-30 (anti-sense); P2y2, 50-CCGAGAGCTCTTTAGCCATTT-30
(sense) and 50-GCCATAAGCACGTAACAGACC-30 (anti-sense); Gapdh, 50-
TCCACCACCCTGTTGCTGTA-30 (sense) and 50-ACCACAGTCCATGCCAT
CAC-30 (anti-sense); LCMV GP, 50-CATTCACCTGGACTTTGTCAGACTC-30
(sense) and 50-GCAACTGCTGTGTTCCCGAAAC-30 (anti-sense); LCMV NP,
50-CAATGGACGCAAGCATTGAG-30 (sense) and 50-GTTCTTCTGCACT
GAGCCTCC-30 (anti-sense); Mfge8, 50-GATCTTTCCAAC AACCT GCCT
CC-30 (sense) and 50-ACCGCTTTCATCCTGGATGAACTC-30 (ant-sense);
Bai1, 50-GCTGGCAGAAGCTGACGAT-30 (sense) and 50-CACGGAGATGACC
TTAGAGTTG-30 (anti-sense); Stab2, 50-GCTGTCGTCCTGGTTACTG-30
(sense) and 50-CCAAGGCATCAATGTCATC-30 (antisense); Tyro3, 50-TGCCTG
CTTCGGAACTTG-30 (sense) and 50-GCCTGAGTCGGTACGAATG-30 (anti-
sense); Axl, 50-CCAGTCACAGGACACAGCTC-30 (sense) and 50-GTGACTC
CCTTGGCATTG-30 (anti-sense); Mertk, 50-GGAAAGCGCAGGGACTTAC-30
(sense) and 50-CTGTGCAGGTGGCATTGTG-30 (anti-sense); and Gas6, 50-
GGCATGTGGCAAACT ATCT-30 (sense) and 50-CGAGCTCACTCTCC
TTGAA30 (antisense). Primers were synthesized for Ccr2, P2y2, LCMV GP
(Ejrnaes et al., 2006), LCMV NP (Djavani et al., 2001), Mfge8, Bai1, Stab2,
Tyro3, Axl, Mertk, and Gas6 by Operon Biotechnology, and for Gapdh by
Toyobo.
Ex Vivo Hemophagocytosis Assay
TER119 Mo-DCs and TER119+ erythroid cells or Gr1hiLy6c+ granulocytes
were separately sorted from the BM of either WT orMfge8/mice at 12 hr af-
ter LCMV C13 infection. The Mo-DCs were precultured in 10% FCS-RPMI
supplemented with 20 ng/ml GM-CSF, washed, then incubated with either iso-
type Ab cocktails (50 mg/ml of each) or blocking antibodies against Tim1, Tim4,
av, b3, or avb5 (Su et al., 2007) (50 mg/ml of each). TER119
+ erythroid cells were
labeled with pHrodo-SE (0.5 mg/ml, Life Technologies) at room temperature for
30 min, then washed with 10% FCS PBS after stopping the reaction with 1 ml
100%FCS. To opsonize TER119+ erythroid cells, the cells were incubated with
goat serum at 4C for 1 hr, washed, then incubated with anti-goat IgG antibody
at 4C for 1 hr. The Mo-DCs (4 3 104) and pHrodo-labeled erythroid cells
(4 3 105), opsonized erythroid cells (4 3 105), or granulocytes (2 3 105) were
cocultured in 100 ml of 10% FCS-RPMI supplemented with 20 ng/ml GM-CSF
in 96 well U-bottom Ultra-Low Attached plate (Corning) at 37C for 2 hr for
Diff-Quick staining and flow cytometry or 24 hr for ELISA. To block internaliza-
tion of apoptotic erythroid cells intoMo-DCs, we added control DMSO (0.01%)
or cytochalasin D (5 mM) in culture for 2 hr, washed it out, then subjected 24 hr
supernatants to IL-10 ELISA.
Ex Vivo Induction of PS and PS Receptors by IFN-a
Erythroid cells and granulocytes, sorted from theBMofWTmice, and T cells, B
cells, NK cells, sorted from the spleen ofWTmice, were stimulated ex vivo with
different doses of IFN-a for 18 hr and then subjected to annexin V staining. In
addition, inflammatory monocytes, sorted from the BM ofWTmice, were stim-
ulated ex vivo with IFN-a (1 3 104 U/ml) for 24 hr and then, subjected to the
analysis of PS receptor expression.
Statistical Analysis
We evaluated the statistical significance of the obtained values by Student’s
t test. We considered a p value < 0.05 as significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
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